Pemigatinib + Afatinib in Advanced Refractory Solid Tumors
Massachusetts General Hospital
Massachusetts General Hospital
West China Hospital
Petrov, Andrey
Dana-Farber Cancer Institute
West China Hospital
University of California, Davis
OHSU Knight Cancer Institute
National Cancer Centre, Singapore
University of Washington
Vanderbilt-Ingram Cancer Center
Saint John's Cancer Institute
H. Lee Moffitt Cancer Center and Research Institute
Johannes Gutenberg University Mainz
Vanderbilt-Ingram Cancer Center
Yonsei University
Ludwig-Maximilians - University of Munich
Groupe Oncologie Radiotherapie Tete et Cou
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center